Alar Pharmaceuticals Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 08, 2025: 200.63

Alar Pharmaceuticals Inc. Enterprise Value to EBITDA (EV/EBITDA) is 200.63 on July 08, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Alar Pharmaceuticals Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 222.01 on July 08, 2025, which is 10.66% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Alar Pharmaceuticals Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 102.03 on July 08, 2025, which is -49.15% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Alar Pharmaceuticals Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 173.40.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization